Eupraxia Pharmaceuticals clinical trials we track

Check company identity source

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the KneeNCT04120402EP-104IAR 25 mg, VehicleCompleted2023-05-17Actual

Phase 1 / 2 1 trial

TrialDrugs studiedStatusPrimary completion
A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).NCT05608681EP-104GIRecruiting2026-12Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.